Task force on sudden cardiac death of the European Society of Cardiology

SG Priori, E Aliot, C Blomstrom-Lundqvist… - European heart …, 2001 - academic.oup.com
The members of the Task Force on Sudden Death dedicate this paper to the memory of our
former friend and colleague, Professor Ronald WF Campbell. Ronnie spent his life working …

Antipsychotic-related QTc prolongation, torsade de pointes and sudden death

PM Haddad, IM Anderson - Drugs, 2002 - Springer
Sudden unexpected deaths have been reported with antipsychotic use since the early
1960s. In some cases the antipsychotic may be unrelated to death, but in others it appears to …

[PDF][PDF] Policy Conference

W Haverkamp, G Breithardt, AJ Cammm… - European Heart …, 2000 - escardio.org
The scientific and clinical basis of drug-induced QT prolongation and proarrhythmia was
summarized by formal presentations. The speakers were chosen for their particular …

The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications: report on a Policy Conference of the European …

W Haverkamp, G Breithardt, AJ Camm… - Cardiovascular …, 2000 - academic.oup.com
Drugs. Clinical and Regulatory Implications was held at the conference. It is based on
written reports composed by the European Heart House in Sophia Antipolis, France, on the …

Epidemiology of symptomatic drug-induced long QT syndrome and torsade de pointes in Germany

G Sarganas, E Garbe, A Klimpel, RC Hering… - Europace, 2014 - academic.oup.com
Aims Drug-induced long QT syndrome (diLQTS) leading to Torsade de Pointes (TdP) is a
potentially lethal condition, which has led to several post-marketing drug withdrawals in the …

Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling

M Malik, AJ Camm - Drug safety, 2001 - Springer
Assessment of proarrhythmic toxicity of newly developed drugs attracts significant attention
from drug developers and regulatory agencies. Although no guidelines exist for such …

Arrhythmogenic right ventricular dysplasia

G Fontaine, F Fontaliran, JL Hebert… - Annual review of …, 1999 - annualreviews.org
Arrhythmogenic right ventricular dysplasia (ARVD) is a new form of cardiomyopathy
probably more frequent than commonly reported. It is a rare but important cause of sudden …

Enhanced susceptibility for acquired torsade de pointes arrhythmias in the dog with chronic, complete AV block is related to cardiac hypertrophy and electrical …

MA Vos, SHM De Groot, SC Verduyn… - Circulation, 1998 - Am Heart Assoc
Background—Chronic, complete AV block (CAVB) in the dog leads to ventricular
hypertrophy, which has been described as an independent risk factor for arrhythmias. In this …

Ventricular tachycardia ablation: evolution of patients and procedures over 8 years

F Sacher, UB Tedrow, ME Field… - Circulation …, 2008 - Am Heart Assoc
Background—Evolving management of coronary artery disease, heart failure, and the use of
implantable cardioverter-defibrillators impacts the characteristics of patients with recurrent …

Практическая кардиология

НА Мазур - 2012 - elibrary.ru
Данное издание «Практической кардиологии» дополнено новыми данными,
полученными B последние 3 года. Все содержащиеся в книге рекомендации по …